Aphria and the individual defendants have consistently ... This financial update is based on a press release statement from Tilray Brands, Inc. and the information contained in their recent ...

This deal will create a new company with an equity value of about C$4.8 billion ($3.8 billion), according to a statement and interviews with the Tilray and Aphria chief executive officers.

The next phase will see outdoor cultivation in Cayuga, Ontario this spring. Tilray’s key Canadian facilities, Aphria One and Aphria Diamond, are now fully operational and expected to ...

Additionally, Tilray reached a settlement in a securities class action lawsuit against its subsidiary, Aphria, Inc., agreeing to an aggregate payment of approximately US $21 million. The ...

Morningstar brands and products Company Portfolio ...

Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of ...

Tilray has been a leader in the cannabis industry in the recent years. This market has been a major disappointment despite the hopes and expectations investors placed in it after encouraging ...

Phase II of the growth plan includes planting the outdoor cultivation site in Cayuga this spring. Tilray’s primary Canadian production facilities, Aphria One and Aphria Diamond, are now fully planted ...